Patients with GLP-1 receptor agonists or dual GIP and GLP-1 receptor agonist use during the 12-month baseline period were excluded, as were those with diabetes, prior metabolic bariatric procedures, or conditions associated with unintentional weight change
This is the most important question to ask when building a routine
A 2016 retrospective analysis of 57 LJISSA cases demonstrated improved glycemic control in all patients, with 34 achieving complete diabetes remission and 23 requiring reduced hypoglycemic medications by 12 months
If you cannot meet needs through whole foods, consider protein powder in smoothies or shakes
Zepbound (tirzepatide) is one of the newest and most effective GLP-1/GIP medications for weight loss
This includes out-of-pocket costs, like copays, medical deductibles, and medical screenings